MS decreases the larger amplitude distribution in adult rats. حسب Jesús David Ayala-Rodríguez (17364296)

Metabolites with significantly increased abundance in murine nasopharynx vs lungs. حسب Angharad E. Green (9667606)

Metabolites with significantly increased abundance in murine lungs vs nasopharynx. حسب Angharad E. Green (9667606)

ACEi or ARB do not affect expression of ACE2 in lung epithelial cells. حسب Sebastian Cremer (11592273)

الموضوعات:

Matrix crosslinking decreases cell migration persistence. حسب Michael Pamonag (12295175)

A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. حسب Benedict J. Alter (9745466)

Correlations of cytokines that significantly change between the pre-infusion and post-infusion blood draws pearson’s correlation between cytokine pairs is indicated by color and si... حسب Jordan K. Abbott (8934239)

الموضوعات:

Larger example of stimuli with cue relevant for Task 3. حسب Marcel F. Hinss (14675457)

Long COVID prevalence decreases with vaccine uptake in the U.S. حسب Manlio De Domenico (626037)

"…<p>(A) Prevalence in U.S. states and the U.S. exhibits a decreasing trend with respect to vaccine uptake, both in the population vaccinated with at least one dose (top) and two doses (bottom), with the largest gap between 100% vaccinated and 100% unvaccinated scenarios observed in the reference population of adults who had COVID-19. …"

Points represent regions where the cluster coefficient was significantly larger in HC compared to MCI, at sparsity level of 0.15. حسب Therese M. Gilligan (7460906)

Decrease of injuries. حسب Petr Fulin (8380320)

الموضوعات:

Example of predicted effects of choice bundling on preference for larger, later rewards (LLRs) over smaller, sooner rewards (SSRs). حسب Jeffrey S. Stein (11689918)

Decrease of admissions and lead diagnoses. حسب Petr Fulin (8380320)

الموضوعات:

Sensitivity analyses of seroprevalence with the largest sample size study omitted. حسب Yu Zhou (89766)

Kaplan-Meier analysis, patients with CVD and/or hypertension, baseline uncomplicated. حسب Sebastian Cremer (11592273)

الموضوعات:

Baseline characteristics of patients in the uncomplicated phase of COVID-19. حسب Sebastian Cremer (11592273)

الموضوعات:

Biomarkers in uncomplicated patients with CVD/Hypertension. حسب Sebastian Cremer (11592273)

الموضوعات:

Mortality risk in patients with CVD and hypertension. حسب Sebastian Cremer (11592273)

الموضوعات:

Mortality risk in patients with CVD and hypertension—Advanced disease. حسب Sebastian Cremer (11592273)

الموضوعات:

Biomarkers in all patients with CVD/Hypertension. حسب Sebastian Cremer (11592273)

الموضوعات: